ANGPTL3 and Hypertension: Similar to the entire population of the study, T2D subjects with hypertension had higher circulating levels of ANGPTL4 (220.06 ± 22.06 ng/mL vs. 163.61 ± 14.03 ng/mL, p = 0.03) and ANGPTL8 (2671.68 ± 230.75 pg/mL vs. 2026.87 ± 195.50 pg/mL, p = 0.04) but not ANGPTL3 (70.63 ± 4.09 ng/mL vs. 68.67 ± 8.20 ng/mL, p = 0.83) (Fig. 2a, b & c).